PFE
Pfizer
Health Care
Pharmaceuticals
New York City, New York
Last filing: Feb 26, 2026 (FY2025)
Balance Sheet 13 Accounts • 5 Years
| Account | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| BS_Assets_ShortTermInvest | $0 | $10.9B | $4.4B | $18.7B | $22.0B |
| BS_Assets_AcctsReceivable | $0 | $11.5B | $11.2B | $11.0B | $11.5B |
| BS_Assets_Inventory | $0 | $10.9B | $10.2B | $9.0B | $9.1B |
| BS_Assets_PPE | $0 | $18.4B | $18.9B | $16.3B | $14.9B |
| BS_Assets_Goodwill | $2.7B | $68.5B | $67.8B | $51.4B | $49.2B |
| BS_Assets_IntangibleAssets | $0 | $55.4B | $64.9B | $43.4B | $25.1B |
| BS_Assets_OtherNoncurrent | $0 | $9.8B | $12.5B | $13.2B | $7.7B |
| BS_Liab_AccruedLiab | $0 | $6.3B | $5.1B | $5.7B | $5.6B |
| BS_Liab_OtherCurrent | $0 | $19.7B | $20.5B | $22.6B | $24.9B |
| BS_Liab_OtherNoncurrent | $0 | $14.2B | $16.5B | $13.2B | $9.7B |
| BS_Equity_PreferredStock | $0 | $27.0M | $27.0M | $0 | $0 |
| BS_Equity_CommonStock | $0 | $480.0M | $478.0M | $476.0M | $473.0M |
| BS_Equity_TreasuryStock | $0 | $114.8B | $114.5B | $114.0B | $111.4B |